Jacobio Pharmaceuticals Group Co., Ltd. Stock
Equities
1167
KYG4987A1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 HKD | +1.06% | +1.60% | -47.51% |
Sales 2024 * | - | Sales 2025 * | 60.31M 8.33M 65.06M | Capitalization | 1.39B 193M 1.5B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 462M 63.86M 499M | Net cash position 2025 * | 703M 97.04M 758M | EV / Sales 2025 * | 11.5 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 301 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.92% |
1 day | +1.06% | ||
1 week | +1.60% | ||
Current month | +12.43% | ||
1 month | +25.00% | ||
3 months | -21.81% | ||
6 months | -53.66% | ||
Current year | -47.51% |
Managers | Title | Age | Since |
---|---|---|---|
Yin Xin Wang
CEO | Chief Executive Officer | 59 | 18-05-31 |
Hai Jun Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 54 | 20-07-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rui Lin Song
BRD | Director/Board Member | 61 | 20-08-19 |
Xiaojie Wang
ADM | Chief Administrative Officer | 60 | 18-07-30 |
Yun Yan Hu
BRD | Director/Board Member | 61 | 18-07-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.85% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.9 | +1.06% | 1,425,600 |
24-05-23 | 1.88 | -0.53% | 1,069,500 |
24-05-22 | 1.89 | +0.53% | 940,500 |
24-05-21 | 1.88 | -4.08% | 1,035,600 |
24-05-20 | 1.96 | +4.81% | 1,489,200 |
Delayed Quote Hong Kong S.E., May 24, 2024 at 04:08 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.51% | 193M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 1167 Stock